HighTide Therapeutics is a global clinical-stage biopharmaceutical company focused on discovering and developing novel drugs to treat chronic liver diseases, gastrointestinal diseases and metabolic disorders with high unmet needs. The company integrates expertise in disease biology, medicinal chemistry, clinical development and regulatory affairs to advance its growing pipeline of drugs. The company’s lead drug candidate, HTD1801, is a first-in-class new molecular entity, currently in Phase II trials for the treatment of primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH). The FDA has granted HTD1801 Fast Track Designation in both diseases. HighTide Therapeutics was established in 2011 by Liping Liu in Shenzhen, Guangdong.

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, they are focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. Pirfenidone, the only medicine approved for IPF anywhere in the world, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.

Meiyitian Biomedicine (Wuhan) Co., Ltd., established on 2018-04-02, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Healthy food(prepackaged)Sales;Food Internet Sales(Only sell prepackaged food);General merchandise sales;Cosmetics Retail;Household Goods Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Experimental analysis instrument sales;Health Consulting Services(Does not include medical services);Data processing and storage support services;Information Consulting Service(Not including licensing information consulting services);Environmental Consulting Services;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;New material technology research and development;Biochemical product technology research and development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Production of Class I Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Nihon Nohyaku Co., Ltd. engages in the manufacture of agrochemical and pharmaceutical products. It operates through the following segments: Agrochemical, Chemical Products (except agrochemical), and Others. The Agrochemical segment produces and sells insecticides, fungicides, herbicides, pesticides, and other agrochemicals. The Chemical Products segment manufactures and distributes wood chemicals, water treatment agents, agrochemical materials, and pharmaceutical products. The Others segment deals with landscaping and greening construction, real estate leasing, logistics services, and pesticide residue analysis. The company was founded on November 17, 1928 and is headquartered in Tokyo, Japan.

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Canon Marketing Japan, Inc. engages in the domestic marketing of Canon products and related solutions. It operates through the following segments: Consumer, Enterprise, Area, Professional, and Others. The Consumer segment provides digital cameras and inkjet printers mainly for individual customers. The Enterprise segment offers input/output devices and solutions that contribute to solving management issues for large companies. The Area segment deals with input/output devices and solutions for small and medium-sized enterprises. The Professional segment manufactures and sells commercial printers mainly for the printing industry. The Others segment includes call center and business process outsourcing services. The company was founded on February 1, 1968 and is headquartered in Tokyo, Japan.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Moon (Guangzhou) Biotechnology Co., Ltd., established on 2016-11-22, The business scope includes the manufacture of biochemical pesticides and microbial pesticides;Chemicals,Biological product(Contains vaccine)wholesale;Biopharmaceutical Manufacturing;Wholesale Prepackaged Food;Health food wholesale(Specific business items are<food business license>prevail);Sales of formula foods for special medical purposes;Bulk Food Wholesale;Prepackaged Food Retail;Health Food Retail(Specific business items are<food business license>prevail);Bulk Food Retail;Food Operations Management;Food Testing Services;online food sales;laboratory testing(Those involving licensed projects need to obtain a license before they can engage in business operations);Commodity wholesale trade(Except for licensed and approved products);Import and export(Excluding franchised products);Technology Import and Export;Wholesale of chemical products(Excluding hazardous chemicals);Feed Additives Wholesale;feed wholesale;Wholesale of Organic Fertilizers and Microbial Fertilizers;Food Science and Technology Research Services;Research and development of formula food for special medical purpose;Wholesale of cosmetics and hygiene products;Retailing of cosmetics and hygiene products;Agricultural Science Research and Experimental Development;Natural science research and experimental development;Medical Research and Experimental Development;Agricultural pest control services;Manufacture of organic fertilizers and microbial fertilizers;Biomedical Technology Research;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Manufacture of special pharmaceutical materials for environmental pollution treatment(Monitor Chemicals,Excluding hazardous chemicals);

Sinew Pharma, Inc. engages in the research and development of drugs related to liver disease treatment and pain treatment. It develops acetaminophen, drugs for non-alcoholic steatohepatitis, and acetaminophen poisoning antidotes. The company was founded by Kai Min Chu on June 18, 2014 and is headquartered in Taipei, Taiwan.

Shaanxi Juzi Biotechnology Co., Ltd., established on 2009-03-12, Business scope includes general items:Production of Class I Medical Devices;Manufacturing of bio-based materials;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Chemical product sales(No licensed chemical products);Cosmetics Wholesale.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Production of hygiene products and single-use medical products;Class III medical device business;Import and export;Technology Import and Export;food production;Health food production;Health food sales;food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Heilongjiang Jiren Pharmaceutical Co., Ltd., established on 1996-09-27, The business scope includes production and sales within the scope approved by the drug production enterprise license;Goods import and export trade;Drug Testing Services;food technology development,technology transfer;Pre-packaged food(Does not contain refrigerated frozen food)Sales(The food business license is valid until2023year6moon6day);Internet information service.

TOYO SHINYAKU Co., Ltd. engages in the consigned manufacture and sale of health food products, medicines, cosmetics, ingredients for quasi drugs and foshu products. The company was founded on March 19, 1993 and is headquartered in Fukuoka, Japan.

Guizhou Zhukang Liquor Co., Ltd., established on 2021-05-25, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Other general retail;liquor business;food business;wine production;Food import and export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments))

The Lee Co. supplies precision fluid control products to industries including aerospace, formula 1 racing, oil exploration, automotive and off-highway equipment, and medical and scientific instruments. Its products include precision microhydraulics and electro-fluidic systems. The company was founded by Leighton Lee II in 1948 and is headquartered in Westbrook, CT.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Shandong Shanwei Immune Technology Co., Ltd., established on 2020-12-29, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Natural science research and experimental development;Food Additive Sales;Bio-feed R&D;Feed Raw Material Sales;Feed Additive Sales;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Healthy food(prepackaged)Sales;Sales of formula food for special medical purposes;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Food import and export;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food production;food sales;Food Internet Sales;Health food production;Food additive production;Production of formula food for special medical purpose;Inspection and testing service;Drug import and export;Drug retail;Drug Wholesale;Feed additive production;feed production;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Pharmaceutical commissioned production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shandong Qingyu Jiangxing Biotechnology Co., Ltd., established on 2020-06-19, Business scope includes biotechnology development,Technical Services,technical consulting,technology transfer;Pre-packaged food,bulk food,Healthy food,Health Supplies,Class II medical device,Daily necessities,Cleaning Products,hygiene products,household products,Instrumentation,household appliances,electronic product,Kitchenware,beauty equipment,cosmetic,Skin care sales;Product Design Services;packaging service;Advertising Design,acting,release;Graphic design and production;Enterprise Management Information Consulting;food,Technology development in the field of medical science and technology,Technical Services,technical consulting,technology transfer;Cosmetic research and development(Does not include production);Online Trade Agent;Health Care Services;Health Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

West China Second University Hospital is a Chinese private company located in Chengdu. The firm provides women and children healthcare services.

Heilongjiang Rutai Technology Development Co., Ltd., established on 2015-11-30, Business scope includes biomedical research and development,Health product research and development,Medical device research and development,health care consultation,Research and development of chemical materials,Research and development of energy and environmental protection products;Food production and sales,Pharmaceutical production and wholesale.